Medicure Inc.
MPH.V
TSX
Weiss Ratings | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | D | |||
Rating Factors | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.20 | |||
Price History | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -10.67% | |||
30-Day Total Return | -18.29% | |||
60-Day Total Return | -31.63% | |||
90-Day Total Return | -23.86% | |||
Year to Date Total Return | -22.99% | |||
1-Year Total Return | -40.18% | |||
2-Year Total Return | -35.58% | |||
3-Year Total Return | -35.58% | |||
5-Year Total Return | -65.64% | |||
52-Week High % Change | -29.37% | |||
52-Week Low % Change | 36.92% | |||
Price | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $1.26 | |||
52-Week Low Price | $0.65 | |||
52-Week Low Price (Date) | Feb 26, 2025 | |||
52-Week High Price (Date) | Jul 30, 2024 | |||
Valuation | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 6.46M | |||
Enterprise Value | 3.70M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.15 | |||
Earnings Per Share Growth | -302.09% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.60 | |||
Price/Book (Q) | 0.63 | |||
Enterprise Value/Revenue (TTM) | 0.24 | |||
Price | $0.67 | |||
Enterprise Value/EBITDA (TTM) | -2.18 | |||
Enterprise Value/EBIT | -1.22 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 10.44M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 204 487 7412 | |||
Address | 2-1250 Waverley Street Winnipeg, MB R3T 6C6 | |||
Website | www.medicure.com | |||
Country | Canada | |||
Year Founded | 1997 | |||
Profitability | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -19.47% | |||
Profit Margin | -9.61% | |||
Management Effectiveness | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -8.90% | |||
Return on Equity | -- | |||
Income Statement | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 15.50M | |||
Total Revenue (TTM) | 15.50M | |||
Revenue Per Share | $1.49 | |||
Gross Profit (TTM) | 8.63M | |||
EBITDA (TTM) | -1.69M | |||
EBIT (TTM) | -3.02M | |||
Net Income (TTM) | -1.49M | |||
Net Income Avl. to Common (TTM) | -1.49M | |||
Total Revenue Growth (Q YOY) | 1.31% | |||
Earnings Growth (Q YOY) | 696.49% | |||
EPS Diluted (TTM) | -0.15 | |||
EPS Diluted Growth (Q YOY) | 696.67% | |||
Balance Sheet | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 3.62M | |||
Cash Per Share (Q) | $0.35 | |||
Total Current Assets (Q) | 11.95M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 14.79M | |||
Current Ratio (Q) | 2.030 | |||
Book Value Per Share (Q) | $1.42 | |||
Total Assets (Q) | 21.09M | |||
Total Current Liabilities (Q) | 5.89M | |||
Total Debt (Q) | 688.40K | |||
Total Liabilities (Q) | 6.30M | |||
Total Common Equity (Q) | 14.79M | |||
Cash Flow | MPH.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -307.90K | |||
Cash from Financing (TTM) | -236.70K | |||
Net Change in Cash (TTM) | -547.60K | |||
Levered Free Cash Flow (TTM) | -671.20K | |||
Cash from Operations (TTM) | -3.00K | |||